Analyst Reco. Eli Lilly and Company NEO Exchange

Equities

LLY

CA28655A1066

End-of-day quote NEO Exchange Other stock markets 23:00:00 04/07/2024 BST			5-day change	1st Jan Change
34.33 ^CAD	+1.33%		+0.94%	+55.76%

07-04	ETF of the week: Investing in strong trends with the momentum theme
07-03	Health Stocks Slip in Risk-On Trade -- Health Care Roundup	DJ

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell Wednesday; Tesla to Advance, Reddit to Decline	07-03	MT
Goldman Sachs Adjusts Price Target on Eli Lilly & Co. to $793 From $785, Maintains Neutral Rating	07-03	MT
Jefferies Adjusts Price Target on Eli Lilly & Co. to $1,041 From $1,015, Maintains Buy Rating	07-03	MT
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices	07-03	MT
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	07-02	MT
Biden says Novo Nordisk must cut prices of diabetes, weight loss drugs	07-02	RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say in USA Today Op-Ed	07-02	MT
Social Buzz: Wallstreetbets Stocks Mixed Premarket Monday; Tesla to Advance, Nvidia to Decline	07-01	MT
ANALYST RECOMMENDATIONS : Capri Holdings, Adobe, Broadcom, Celanese, Admiral...	06-25
Truist Adjusts Price Target on Eli Lilly & Co. to $1,000 From $892 After Model Update, Maintains Buy Rating	06-25	MT
Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update	06-24	DJ
Jefferies Adjusts Price Target on Eli Lilly to $1,015 From $994	06-24	MT
BIOGEN EXEC SAYS THE ALZHEIMER'S DRUG MARKET "WILL DEVELOP FASTE…	06-12	RE
Social Buzz: Wallstreetbets Stocks Mixed Premarket Wednesday; Oracle to Advance, AST SpaceMobile to Open Lower	06-12	MT
Jefferies Adjusts Price Target on Eli Lilly and Co. to $994 From $957	06-11	MT
Jefferies Adjusts Price Target on Eli Lilly to $957 From $925	06-07	MT
Goldman Sachs Adjusts Price Target on Eli Lilly to $785 From $740	05-30	MT
Jefferies Adjusts Price Target on Eli Lilly to $925 From $915	05-23	MT
Social Buzz: Wallstreetbets Stocks Mixed Pre-Bell; Hims & Hers Health to Advance, AMC Entertainment to Decline	05-21	MT
Argus Adjusts Price Target on Eli Lilly to $840 From $770	05-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 12, 2024 at 06:47 pm